Patents by Inventor David Tacha

David Tacha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10429390
    Abstract: The present invention relates to compositions and detection systems of antibodies or fragments thereof, wherein at least two antibodies or fragments thereof binds specifically to squamous cell carcinoma (SCC) and/or adenocarcinoma (ADC). Methods for using the antibodies in diagnosis, prognosis, and assessing efficacy of treatment is further included as well as kits including such compositions and detection systems.
    Type: Grant
    Filed: December 18, 2013
    Date of Patent: October 1, 2019
    Assignee: Biocare Medical, LLC
    Inventor: David Tacha
  • Patent number: 10316103
    Abstract: The present invention is related to the anti-Uroplakin III antibodies, kits, cocktails, and use of anti-Uroplakin III antibodies for detection of cancer.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: June 11, 2019
    Assignee: Biocare Medical, LLC
    Inventors: Weimin Qi, David Tacha
  • Patent number: 10295542
    Abstract: The present invention is related to the anti-SOX10 antibodies, kits, cocktails, and use of anti-SOX10 antibodies for detection of cancer.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: May 21, 2019
    Assignee: Biocare Medical, LLC
    Inventors: David Tacha, Weimin Qi
  • Patent number: 9945763
    Abstract: Heat induced antigen retrieval systems for biological specimens may include a sealable heating pressure chamber, a programmable process controller, a nonpareil operating element, and perhaps even a substantially user-disencumbering autonomous processing component of a plurality of biological samples perhaps using various user selected protocols, and the like.
    Type: Grant
    Filed: February 21, 2012
    Date of Patent: April 17, 2018
    Assignee: Biocare Medical, LLC
    Inventors: David Tacha, Thomas Maxwell, Evan Barker, Hoa Nguyen, Ravishankar Melkote
  • Publication number: 20180074065
    Abstract: The present invention is related to the anti-SOX10 antibodies, kits, cocktails, and use of anti-SOX10 antibodies for detection of cancer.
    Type: Application
    Filed: November 13, 2017
    Publication date: March 15, 2018
    Inventors: David Tacha, Weimin Qi
  • Patent number: 9823251
    Abstract: The present invention is related to the anti-Uroplakin II antibodies, kits, cocktails, and use of anti-Uroplakin II antibodies for detection of cancer.
    Type: Grant
    Filed: August 2, 2016
    Date of Patent: November 21, 2017
    Assignee: Biocare Medical, LLC
    Inventors: Weimin Qi, David Tacha
  • Patent number: 9816997
    Abstract: The present invention is related to the anti-SOX10 antibodies, kits, cocktails, and use of anti-SOX10 antibodies for detection of cancer.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: November 14, 2017
    Assignee: Biocare Medical, LLC
    Inventors: David Tacha, Weimin Qi
  • Patent number: 9708395
    Abstract: The present invention is related to the anti-p40 antibodies, kits, cocktails, and use of anti-p40 antibodies for detection of cancer.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: July 18, 2017
    Assignee: Biocare Medical, LLC
    Inventors: David Tacha, Weimin Qi
  • Publication number: 20160370370
    Abstract: The present invention is related to the anti-PAX8 antibodies, kits, cocktails, and use of anti-PAX8 antibodies for detection of cancer.
    Type: Application
    Filed: July 28, 2016
    Publication date: December 22, 2016
    Inventors: Weimin Qi, David Tacha
  • Publication number: 20160333085
    Abstract: The present invention is related to the anti-p40 antibodies, kits, cocktails, and use of anti-p40 antibodies for detection of cancer.
    Type: Application
    Filed: August 4, 2016
    Publication date: November 17, 2016
    Inventors: David Tacha, Weimin Qi
  • Publication number: 20160334407
    Abstract: The present invention is related to the anti-Uroplakin II antibodies, kits, cocktails, and use of anti-Uroplakin II antibodies for detection of cancer.
    Type: Application
    Filed: August 2, 2016
    Publication date: November 17, 2016
    Inventors: Weimin Qi, David Tacha
  • Patent number: 9429577
    Abstract: The present invention is related to the anti-Uroplakin II antibodies, kits, cocktails, and use of anti-Uroplakin II antibodies for detection of cancer.
    Type: Grant
    Filed: September 26, 2013
    Date of Patent: August 30, 2016
    Assignee: Biocare Medical, LLC
    Inventors: Weimin Qi, David Tacha
  • Patent number: 9428576
    Abstract: The present invention is related to the anti-p40 antibodies, kits, cocktails, and use of anti-p40 antibodies for detection of cancer.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: August 30, 2016
    Assignee: Biocare Medical, LLC
    Inventors: David Tacha, Weimin Qi
  • Patent number: 9417243
    Abstract: The present invention is related to the anti-PAX8 antibodies, kits, cocktails, and use of anti-PAX8 antibodies for detection of cancer.
    Type: Grant
    Filed: October 6, 2014
    Date of Patent: August 16, 2016
    Assignee: Biocare Medical, LLC
    Inventors: Weimin Qi, David Tacha
  • Publication number: 20160216269
    Abstract: The present invention is related to the anti-SOX10 antibodies, kits, cocktails, and use of anti-SOX10 antibodies for detection of cancer.
    Type: Application
    Filed: October 3, 2014
    Publication date: July 28, 2016
    Inventors: David Tacha, Weimin Qi
  • Publication number: 20160009795
    Abstract: The present invention is related to the anti-p40 antibodies, kits, cocktails, and use of anti-p40 antibodies for detection of cancer.
    Type: Application
    Filed: August 28, 2015
    Publication date: January 14, 2016
    Inventors: David Tacha, Weimin Qi
  • Publication number: 20150309035
    Abstract: The present invention relates to compositions and detection systems of antibodies or fragments thereof, wherein at least two antibodies or fragments thereof binds specifically to squamous cell carcinoma (SCC) and/or adenocarcinoma (ADC). Methods for using the antibodies in diagnosis, prognosis, and assessing efficacy of treatment is further included as well as kits including such compositions and detection systems.
    Type: Application
    Filed: December 18, 2013
    Publication date: October 29, 2015
    Applicant: Biocare Medical LLC
    Inventor: David Tacha
  • Publication number: 20150247861
    Abstract: The present invention is related to the anti-Uroplakin II antibodies, kits, cocktails, and use of anti-Uroplakin II antibodies for detection of cancer.
    Type: Application
    Filed: September 26, 2013
    Publication date: September 3, 2015
    Inventors: Weimin Qi, David Tacha
  • Publication number: 20150056635
    Abstract: The present invention is related to the anti-PAX8 antibodies, kits, cocktails, and use of anti-PAX8 antibodies for detection of cancer.
    Type: Application
    Filed: October 6, 2014
    Publication date: February 26, 2015
    Inventors: Weimin Qi, David Tacha
  • Patent number: 8852592
    Abstract: The present invention is related to the anti-PAX8 antibodies, kits, cocktails, and use of anti-PAX8 antibodies for detection of cancer.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: October 7, 2014
    Assignee: Biocare Medical, LLC
    Inventors: Weimin Qi, David Tacha